ARCHIVES

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

This article is from The Cancer Letter archive.

Vol. 30 No. 10 | October 26, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Grand Jury To Consider Charges Against N.M. Community Based Cancer Program Staff Members

January 4, 1980

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

September 7, 1990

Full Clearinghouse To Meet; Members Reveal Interests In Evaluations

October 28, 1977

Advocacy: Friends To Continue Another Year

June 13, 1997